Bimekizumab

Definition: Bimekizumab, sold under the brand name Bimzelx ( bim-ZEL-iks), is a humanized anti-IL17A, anti-IL-17F, and anti-IL17AF monoclonal antibody that is used to treat plaque psoriasis, psoriatic arthritis, axial spondyloarthritis, ankylosing spondylitis, and hidradenitis suppurativa. The most common side effects include upper respiratory tract infections (nose and throat infection) and oral candidiasis (thrush, a fungal infection in the mouth or throat). Injection site reactions were also common, repo... source: Wikipedia

ID

278221000202100

ID date

16 May 2024

Previous ID

39934811000001107

Name

Bimekizumab